Secondary Immunodeficiency and Hypogammaglobulinemia with IgG Levels of <5 g/L in Patients with Multiple Myeloma: A Retrospective Study Between 2012 and 2020 at a University Hospital in China

09 July 2021 : Clinical Research

Chunmei Ye^12BCEF, Weiwei Chen^3EF, Qi Gao^12B, Yanxia Chen^4B, Xiaolu Song^5B, Sujie Zheng^2C, Jinlin Liu^2AEG*

DOI: 10.12659/MSM.930241

Med Sci Monit 2021; 27:e930241

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Flow chart of the selection of multiple myeloma (MM) patients with or without secondary immunodeficiency (SID).

Back to the Article